1. Home
  2. ARWR vs TPH Comparison

ARWR vs TPH Comparison

Compare ARWR & TPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARWR
  • TPH
  • Stock Information
  • Founded
  • ARWR 2003
  • TPH 2009
  • Country
  • ARWR United States
  • TPH United States
  • Employees
  • ARWR N/A
  • TPH N/A
  • Industry
  • ARWR Biotechnology: Pharmaceutical Preparations
  • TPH Homebuilding
  • Sector
  • ARWR Health Care
  • TPH Consumer Discretionary
  • Exchange
  • ARWR Nasdaq
  • TPH Nasdaq
  • Market Cap
  • ARWR 1.7B
  • TPH 2.7B
  • IPO Year
  • ARWR 1993
  • TPH N/A
  • Fundamental
  • Price
  • ARWR $13.25
  • TPH $30.33
  • Analyst Decision
  • ARWR Buy
  • TPH Buy
  • Analyst Count
  • ARWR 11
  • TPH 5
  • Target Price
  • ARWR $41.44
  • TPH $43.00
  • AVG Volume (30 Days)
  • ARWR 2.2M
  • TPH 1.1M
  • Earning Date
  • ARWR 05-08-2025
  • TPH 04-24-2025
  • Dividend Yield
  • ARWR N/A
  • TPH N/A
  • EPS Growth
  • ARWR N/A
  • TPH 20.35
  • EPS
  • ARWR N/A
  • TPH 4.51
  • Revenue
  • ARWR $2,500,000.00
  • TPH $4,294,395,999.00
  • Revenue This Year
  • ARWR $4,380.43
  • TPH N/A
  • Revenue Next Year
  • ARWR $64.24
  • TPH $6.84
  • P/E Ratio
  • ARWR N/A
  • TPH $6.83
  • Revenue Growth
  • ARWR N/A
  • TPH 10.82
  • 52 Week Low
  • ARWR $9.57
  • TPH $27.90
  • 52 Week High
  • ARWR $30.41
  • TPH $47.78
  • Technical
  • Relative Strength Index (RSI)
  • ARWR 50.85
  • TPH 46.81
  • Support Level
  • ARWR $10.92
  • TPH $28.89
  • Resistance Level
  • ARWR $13.45
  • TPH $32.28
  • Average True Range (ATR)
  • ARWR 1.10
  • TPH 1.38
  • MACD
  • ARWR 0.41
  • TPH 0.19
  • Stochastic Oscillator
  • ARWR 94.85
  • TPH 53.41

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.

About TPH Tri Pointe Homes Inc.

Tri Pointe Homes Inc is an American construction company that focuses on residential construction. The company designs and builds single-family homes and condominiums through its portfolio of six regional housing brands. Its largest regional brands include Maracay Homes, which operates in Arizona, and TRI Pointe and Pardee Homes, which operate in California, Nevada, and Colorado. From a geographic perspective, California is TRI Pointe's largest source of revenue, followed by Arizona and Nevada. The company also operates in Texas, Oregon, and Virginia. TRI Pointe completes approximately 4,000 homes annually with an average selling price around $500,000. TRI Pointe also is involved in the sale and development of land.

Share on Social Networks: